From: Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
Characteristics | n | TRPS1 expression | P value | Spearman | Value (r) | P value | |
---|---|---|---|---|---|---|---|
Negative | Positive | Correlation | |||||
Age(y) | |||||||
≤50 | 70 | 26 | 44 | 0.017 | −0.179 | 0.016 | |
>50 | 110 | 61 | 49 | ||||
Grade | |||||||
I | 11 | 5 | 6 | 0.903 | |||
II | 124 | 59 | 65 | ||||
III | 45 | 23 | 22 | ||||
Pathological stage | |||||||
I | 49 | 23 | 26 | 0.646 | |||
II | 85 | 44 | 41 | ||||
III | 46 | 20 | 26 | ||||
Tumor size | |||||||
<2 | 60 | 26 | 34 | 0.343 | |||
≥2 | 120 | 61 | 59 | ||||
Lymph node metastasis | |||||||
Negative | 94 | 48 | 46 | 0.443 | |||
Positive | 86 | 39 | 47 | ||||
Expression of Ki67 | |||||||
≤25% | 62 | 20 | 42 | 0.002 | −0.233 | 0.002 | |
>25% | 118 | 67 | 51 | ||||
Expression of P53 | |||||||
Negative | 72 | 40 | 32 | 0.113 | |||
Positive | 108 | 47 | 61 | ||||
ERα | |||||||
Negative | 75 | 51 | 24 | <0.001 | 0.333 | <0.001 | |
Positive | 105 | 36 | 69 | ||||
PR | |||||||
Negative | 75 | 50 | 25 | <0.001 | 0.31 | <0.001 | |
Positive | 105 | 37 | 68 | ||||
HER-2 | |||||||
Negative | 124 | 53 | 71 | 0.025 | −0.166 | 0.025 | |
Positive | 56 | 34 | 22 | ||||
E-cadherin | |||||||
Negative | 33 | 24 | 9 | 0.002 | 0.231 | 0.002 | |
Positive | 147 | 63 | 84 | ||||
Slug | |||||||
Negative | 170 | 86 | 84 | 0.019 | 0.186 | 0.012 | |
Positive | 10 | 1 | 9 | ||||
Vimentin | |||||||
Negative | 165 | 84 | 81 | 0.022 | 0.171 | 0.022 | |
Positive | 15 | 3 | 12 | ||||
SMA | |||||||
Negative | 169 | 85 | 84 | 0.039 | 0.154 | 0.039 | |
Positive | 11 | 2 | 9 | ||||
β-catenin | |||||||
Negative | 67 | 42 | 25 | 0.003 | 0.221 | 0.003 | |
Positive | 113 | 45 | 68 | ||||
ERβ | |||||||
≤2 | 92 | 55 | 37 | 0.001 | 0.242 | 0.001 | |
>2 | 87 | 31 | 56 | ||||
IMP3 | |||||||
Negative | 157 | 77 | 80 | 0.618 | |||
Positive | 23 | 10 | 13 |